Indication
Painful periods
9 clinical trials
14 products
1 drug
Clinical trial
The Treatment Efficacy of Posterior Tibia Nerve Neuroprolotherapy on DysmenorrheaStatus: Recruiting, Estimated PCD: 2025-12-31
Product
AcetaminophenClinical trial
Evaluating the Safety and Acceptability of Using Chinese Herbal Medicine in Patients With Primary Dysmenorrhea: A Randomized-controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Product
PlaceboClinical trial
Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder PainStatus: Completed, Estimated PCD: 2020-11-23
Product
NaproxenClinical trial
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women With Moderate to Severe Primary DysmenorrheaStatus: Terminated, Estimated PCD: 2016-09-12
Product
ENG 125 μg + E2 300 μgProduct
Placebo vaginal ringProduct
IbuprofenClinical trial
Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With DysmenorrheaStatus: Recruiting, Estimated PCD: 2025-05-31
Product
Sodium NaproxenDrug
VarlilumabClinical trial
A Multicenter, Randomized, Partially Blinded, Placebo-controlled Clinical Trial to Evaluate the Effect on Primary Dysmenorrhea of Vaginal Rings With an Average Daily Release of 700 μg Nomegestrol Acetate (NOMAC) and 300 μg Estradiol (E2), or 900 μg Nomegestrol Acetate (NOMAC) and 300 μg Estradiol (E2), or 100 μg Etonogestrel (ENG) and 300 μg E2, or 125 μg Etonogestrel (ENG) and 300 μg E2. Protocol MK-8175A/MK-8342B 057 (Abbreviated as P057), Also Known as SCH900121/SCH900432 08257 (Abbreviated as P08257)Status: Completed, Estimated PCD: 2013-09-11
Product
Nomegestrol acetateClinical trial
Deciphering the Hormonal and Nociceptive Mechanisms Underlying Bladder PainStatus: Completed, Estimated PCD: 2020-11-01
Product
Cyclic MicrogestinProduct
Continuous MicrogestinClinical trial
Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) StudyStatus: Terminated, Estimated PCD: 2024-04-30
Product
EtonogestrelClinical trial
The Study on the Therapeutic Effect and Mechanism of Transcutaneous Acupoint Electrical Stimulation in FemaleStatus: Recruiting, Estimated PCD: 2023-12-30